Kaplan-Meier Statistics to Estimate Treatment Success
- PMID: 36166805
- DOI: 10.1097/WNO.0000000000001627
Kaplan-Meier Statistics to Estimate Treatment Success
Conflict of interest statement
The author reports no conflicts of interest.
Comment in
-
Kaplan-Meier Statistics to Estimate Treatment Success: Response.J Neuroophthalmol. 2023 Dec 1;43(4):e361-e362. doi: 10.1097/WNO.0000000000001628. Epub 2022 May 24. J Neuroophthalmol. 2023. PMID: 36166804 No abstract available.
Dataset described in
-
Real-World Clinical Experience With Idebenone in the Treatment of Leber Hereditary Optic Neuropathy.J Neuroophthalmol. 2020 Dec;40(4):558-565. doi: 10.1097/WNO.0000000000001023. J Neuroophthalmol. 2020. PMID: 32991388 Free PMC article. Clinical Trial.
References
REFERENCE
-
- Catarino CB, von Livonius B, Priglinger C, Banik R, Matloob S, Tamhankar MA, Castillo L, Friedburg C, Halfpenny CA, Lincoln JA, Traber GL, Acaroglu G, Black GCM, Doncel C, Fraser CL, Jakubaszko J, Landau K, Langenegger SJ, Muñoz-Negrete FJ, Newman NJ, Poulton J, Scoppettuolo E, Subramanian P, Toosy AT, Vidal M, Vincent AL, Votruba M, Zarowski M, Zermansky A, Lob F, Rudolph G, Mikazans O, Silva M, Llòria X, Metz G, Klopstock T. Real-world clinical experience with idebenone in the treatment of leber hereditary optic neuropathy. J Neuroophthalmol. 2020;40:558–565.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
